_Life

English 한국어 Investment Analysis: Hims & Hers Health, Inc. (NYSE: HIMS) 1. Corporate Overview Company Name: Hims & Hers Health, Inc. Headquarters: San Francisco, California, USA (2269 Chestnut Street) Listing & Ticker: New York Stock Exchange (NYSE), Ticker: HIMS 2. Core Business, Products, and Technology Hims & Hers Health is a direct-to-consumer (DTC) telehealth company that connects patients with healthcare professionals and delivers prescription and over-the-counter medications directly to their homes. The business is divided into "Hims" for men and "Hers" for women. Their flagship offerings include treatments for hair loss, erectile dysfunction (ED), dermatology, mental health, and recently, weight loss (which has emerged as a primary revenue driver). The core technological advantage lies in their data-driven, personalized platform combined with a highly pre...

English 한국어 The GLP-1 Revolution & Pharmaceutical Leaders The US wellness industry has evolved into a staggering $2.1 trillion market by 2026, transitioning decisively from traditional fitness models to deep metabolic health and personalized medicine. A primary catalyst for this revolution is the exponential growth of GLP-1 weight loss treatments. Pharmaceutical titans such as Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are at the forefront of this shift. Eli Lilly continues to solidify its market dominance through the success of Mounjaro and Zepbound, alongside its anticipated next-generation oral therapeutics. Concurrently, Novo Nordisk drives innovation with Wegovy and Ozempic, proving pivotal not just in weight reduction, but in mitigating long-term cardiovascular risks. Consumer Wellness & Telehealth Integration In the consumer arena, forward-thinking companies are successfully blending telemedicine with lifestyle m...